Transgenic mice with defined combinations of drug-inducible reprogramming factors

Proviruses carrying drug-inducible Oct4, Sox2, Klf4 and c-Myc used to derive 'primary' induced pluripotent stem (iPS) cells were segregated through germline transmission, generating mice and cells carrying subsets of the reprogramming factors. Drug treatment produced 'secondary'...

Full description

Saved in:
Bibliographic Details
Published in:Nature biotechnology 2009-02, Vol.27 (2), p.169-171
Main Authors: Jaenisch, Rudolf, Markoulaki, Styliani, Hanna, Jacob, Beard, Caroline, Carey, Bryce W, Cheng, Albert W, Lengner, Christopher J, Dausman, Jessica A, Fu, Dongdong, Gao, Qing, Wu, Su, Cassady, John P
Format: Article
Language:English
Subjects:
Agriculture
Animals
Bioinformatics
Biological and medical sciences
Biomedical and Life Sciences
Biomedical Engineering/Biotechnology
Biomedicine
Biotechnology
brief-communication
Cell Differentiation - drug effects
Cell Differentiation - genetics
Cells, Cultured
Chimera - genetics
Chimera - metabolism
DNA binding proteins
Doxycycline - pharmacology
Female
Fibroblasts - metabolism
Fundamental and applied biological sciences. Psychology
Genetic aspects
Genetic Techniques
Genetically modified mice
Genetics
Health aspects
Health. Pharmaceutical industry
Industrial applications and implications. Economical aspects
Kruppel-Like Transcription Factors - genetics
Kruppel-Like Transcription Factors - metabolism
Life Sciences
Male
Mice
Mice, Transgenic
Miscellaneous
Octamer Transcription Factor-3 - genetics
Octamer Transcription Factor-3 - metabolism
Physiological aspects
Pluripotent Stem Cells
Proto-Oncogene Proteins c-myc - genetics
Proto-Oncogene Proteins c-myc - metabolism
Proviruses - genetics
Proviruses - metabolism
Rodents
SOXB1 Transcription Factors - genetics
SOXB1 Transcription Factors - metabolism
Stem cells
Transcription Factors - drug effects
Transcription Factors - genetics
Transgenic animals
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c659t-6779c54fa382534fdf49f8ce66df1e98f10b7e70d84326efa71f3002eef3f5df3
cites cdi_FETCH-LOGICAL-c659t-6779c54fa382534fdf49f8ce66df1e98f10b7e70d84326efa71f3002eef3f5df3
container_end_page 171
container_issue 2
container_start_page 169
container_title Nature biotechnology
container_volume 27
creator Jaenisch, Rudolf
Markoulaki, Styliani
Hanna, Jacob
Beard, Caroline
Carey, Bryce W
Cheng, Albert W
Lengner, Christopher J
Dausman, Jessica A
Fu, Dongdong
Gao, Qing
Wu, Su
Cassady, John P
description Proviruses carrying drug-inducible Oct4, Sox2, Klf4 and c-Myc used to derive 'primary' induced pluripotent stem (iPS) cells were segregated through germline transmission, generating mice and cells carrying subsets of the reprogramming factors. Drug treatment produced 'secondary' iPS cells only when the missing factor was introduced. This approach creates a defined system for studying reprogramming mechanisms and allows screening of genetically homogeneous cells for compounds that can replace any transcription factor required for iPS cell derivation.
doi_str_mv 10.1038/nbt.1520
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2654270</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A199539032</galeid><sourcerecordid>A199539032</sourcerecordid><originalsourceid>FETCH-LOGICAL-c659t-6779c54fa382534fdf49f8ce66df1e98f10b7e70d84326efa71f3002eef3f5df3</originalsourceid><addsrcrecordid>eNqNkmuL1DAUhoso7roK_gIpgqJgx1zatPkiLIuXhYVFXf0a0vSkk6VNxqT18u89wwzdHUGUhCQkzzlJ3vNm2WNKVpTw5rVvpxWtGLmTHdOqFAUVUtzFNWnqgtBKHGUPUromhIhSiPvZEZW0ojUhx9nHq6h96sE7k4_OQP7DTeu8A-s8dLkJY-u8nlzwKQ827-LcF853s3HtAHmETQx91OPofJ9bbaYQ08PsntVDgkf7-ST78u7t1dmH4uLy_fnZ6UVhRCWnQtS1NFVpNW9YxUvb2VLaxoAQnaUgG0tJW0NNuqbkTIDVNbWcEAZgua06y0-yN7u8m7kdoTPgp6gHtYlu1PGXCtqpwxPv1qoP3xUTVclqggme7xPE8G2GNKnRJQPDoD2EOSkhJGlEI_8JMlLyRnCK4NM_wOswR48qKMYYJ9gFQqsd1OsBlPM24OsMtg6wAMGj9Lh_SqWsuCScYcDLgwBkJvg59XpOSZ1__vT_7OXXQ_bVLbadE5Y84ZBcv57SLuQAf7HDTQwpRbCL1JSorQsVulBtXYjok9uluQH3tkPg2R7QyejBogeNSwvHKBP1VtLlOwmPfA_xRtC_X4p-nSMsyRbgNx77_Ec</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>222302306</pqid></control><display><type>article</type><title>Transgenic mice with defined combinations of drug-inducible reprogramming factors</title><source>Nature</source><creator>Jaenisch, Rudolf ; Markoulaki, Styliani ; Hanna, Jacob ; Beard, Caroline ; Carey, Bryce W ; Cheng, Albert W ; Lengner, Christopher J ; Dausman, Jessica A ; Fu, Dongdong ; Gao, Qing ; Wu, Su ; Cassady, John P</creator><creatorcontrib>Jaenisch, Rudolf ; Markoulaki, Styliani ; Hanna, Jacob ; Beard, Caroline ; Carey, Bryce W ; Cheng, Albert W ; Lengner, Christopher J ; Dausman, Jessica A ; Fu, Dongdong ; Gao, Qing ; Wu, Su ; Cassady, John P</creatorcontrib><description>Proviruses carrying drug-inducible Oct4, Sox2, Klf4 and c-Myc used to derive 'primary' induced pluripotent stem (iPS) cells were segregated through germline transmission, generating mice and cells carrying subsets of the reprogramming factors. Drug treatment produced 'secondary' iPS cells only when the missing factor was introduced. This approach creates a defined system for studying reprogramming mechanisms and allows screening of genetically homogeneous cells for compounds that can replace any transcription factor required for iPS cell derivation.</description><identifier>ISSN: 1087-0156</identifier><identifier>EISSN: 1546-1696</identifier><identifier>DOI: 10.1038/nbt.1520</identifier><identifier>PMID: 19151700</identifier><identifier>CODEN: NABIF9</identifier><language>eng</language><publisher>New York: Nature Publishing Group US</publisher><subject>Agriculture ; Animals ; Bioinformatics ; Biological and medical sciences ; Biomedical and Life Sciences ; Biomedical Engineering/Biotechnology ; Biomedicine ; Biotechnology ; brief-communication ; Cell Differentiation - drug effects ; Cell Differentiation - genetics ; Cells, Cultured ; Chimera - genetics ; Chimera - metabolism ; DNA binding proteins ; Doxycycline - pharmacology ; Female ; Fibroblasts - metabolism ; Fundamental and applied biological sciences. Psychology ; Genetic aspects ; Genetic Techniques ; Genetically modified mice ; Genetics ; Health aspects ; Health. Pharmaceutical industry ; Industrial applications and implications. Economical aspects ; Kruppel-Like Transcription Factors - genetics ; Kruppel-Like Transcription Factors - metabolism ; Life Sciences ; Male ; Mice ; Mice, Transgenic ; Miscellaneous ; Octamer Transcription Factor-3 - genetics ; Octamer Transcription Factor-3 - metabolism ; Physiological aspects ; Pluripotent Stem Cells ; Proto-Oncogene Proteins c-myc - genetics ; Proto-Oncogene Proteins c-myc - metabolism ; Proviruses - genetics ; Proviruses - metabolism ; Rodents ; SOXB1 Transcription Factors - genetics ; SOXB1 Transcription Factors - metabolism ; Stem cells ; Transcription Factors - drug effects ; Transcription Factors - genetics ; Transgenic animals</subject><ispartof>Nature biotechnology, 2009-02, Vol.27 (2), p.169-171</ispartof><rights>Springer Nature America, Inc. 2009</rights><rights>2009 INIST-CNRS</rights><rights>COPYRIGHT 2009 Nature Publishing Group</rights><rights>Copyright Nature Publishing Group Feb 2009</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c659t-6779c54fa382534fdf49f8ce66df1e98f10b7e70d84326efa71f3002eef3f5df3</citedby><cites>FETCH-LOGICAL-c659t-6779c54fa382534fdf49f8ce66df1e98f10b7e70d84326efa71f3002eef3f5df3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,2727,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=21267386$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19151700$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jaenisch, Rudolf</creatorcontrib><creatorcontrib>Markoulaki, Styliani</creatorcontrib><creatorcontrib>Hanna, Jacob</creatorcontrib><creatorcontrib>Beard, Caroline</creatorcontrib><creatorcontrib>Carey, Bryce W</creatorcontrib><creatorcontrib>Cheng, Albert W</creatorcontrib><creatorcontrib>Lengner, Christopher J</creatorcontrib><creatorcontrib>Dausman, Jessica A</creatorcontrib><creatorcontrib>Fu, Dongdong</creatorcontrib><creatorcontrib>Gao, Qing</creatorcontrib><creatorcontrib>Wu, Su</creatorcontrib><creatorcontrib>Cassady, John P</creatorcontrib><title>Transgenic mice with defined combinations of drug-inducible reprogramming factors</title><title>Nature biotechnology</title><addtitle>Nat Biotechnol</addtitle><addtitle>Nat Biotechnol</addtitle><description>Proviruses carrying drug-inducible Oct4, Sox2, Klf4 and c-Myc used to derive 'primary' induced pluripotent stem (iPS) cells were segregated through germline transmission, generating mice and cells carrying subsets of the reprogramming factors. Drug treatment produced 'secondary' iPS cells only when the missing factor was introduced. This approach creates a defined system for studying reprogramming mechanisms and allows screening of genetically homogeneous cells for compounds that can replace any transcription factor required for iPS cell derivation.</description><subject>Agriculture</subject><subject>Animals</subject><subject>Bioinformatics</subject><subject>Biological and medical sciences</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedical Engineering/Biotechnology</subject><subject>Biomedicine</subject><subject>Biotechnology</subject><subject>brief-communication</subject><subject>Cell Differentiation - drug effects</subject><subject>Cell Differentiation - genetics</subject><subject>Cells, Cultured</subject><subject>Chimera - genetics</subject><subject>Chimera - metabolism</subject><subject>DNA binding proteins</subject><subject>Doxycycline - pharmacology</subject><subject>Female</subject><subject>Fibroblasts - metabolism</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Genetic aspects</subject><subject>Genetic Techniques</subject><subject>Genetically modified mice</subject><subject>Genetics</subject><subject>Health aspects</subject><subject>Health. Pharmaceutical industry</subject><subject>Industrial applications and implications. Economical aspects</subject><subject>Kruppel-Like Transcription Factors - genetics</subject><subject>Kruppel-Like Transcription Factors - metabolism</subject><subject>Life Sciences</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Transgenic</subject><subject>Miscellaneous</subject><subject>Octamer Transcription Factor-3 - genetics</subject><subject>Octamer Transcription Factor-3 - metabolism</subject><subject>Physiological aspects</subject><subject>Pluripotent Stem Cells</subject><subject>Proto-Oncogene Proteins c-myc - genetics</subject><subject>Proto-Oncogene Proteins c-myc - metabolism</subject><subject>Proviruses - genetics</subject><subject>Proviruses - metabolism</subject><subject>Rodents</subject><subject>SOXB1 Transcription Factors - genetics</subject><subject>SOXB1 Transcription Factors - metabolism</subject><subject>Stem cells</subject><subject>Transcription Factors - drug effects</subject><subject>Transcription Factors - genetics</subject><subject>Transgenic animals</subject><issn>1087-0156</issn><issn>1546-1696</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNqNkmuL1DAUhoso7roK_gIpgqJgx1zatPkiLIuXhYVFXf0a0vSkk6VNxqT18u89wwzdHUGUhCQkzzlJ3vNm2WNKVpTw5rVvpxWtGLmTHdOqFAUVUtzFNWnqgtBKHGUPUromhIhSiPvZEZW0ojUhx9nHq6h96sE7k4_OQP7DTeu8A-s8dLkJY-u8nlzwKQ827-LcF853s3HtAHmETQx91OPofJ9bbaYQ08PsntVDgkf7-ST78u7t1dmH4uLy_fnZ6UVhRCWnQtS1NFVpNW9YxUvb2VLaxoAQnaUgG0tJW0NNuqbkTIDVNbWcEAZgua06y0-yN7u8m7kdoTPgp6gHtYlu1PGXCtqpwxPv1qoP3xUTVclqggme7xPE8G2GNKnRJQPDoD2EOSkhJGlEI_8JMlLyRnCK4NM_wOswR48qKMYYJ9gFQqsd1OsBlPM24OsMtg6wAMGj9Lh_SqWsuCScYcDLgwBkJvg59XpOSZ1__vT_7OXXQ_bVLbadE5Y84ZBcv57SLuQAf7HDTQwpRbCL1JSorQsVulBtXYjok9uluQH3tkPg2R7QyejBogeNSwvHKBP1VtLlOwmPfA_xRtC_X4p-nSMsyRbgNx77_Ec</recordid><startdate>20090201</startdate><enddate>20090201</enddate><creator>Jaenisch, Rudolf</creator><creator>Markoulaki, Styliani</creator><creator>Hanna, Jacob</creator><creator>Beard, Caroline</creator><creator>Carey, Bryce W</creator><creator>Cheng, Albert W</creator><creator>Lengner, Christopher J</creator><creator>Dausman, Jessica A</creator><creator>Fu, Dongdong</creator><creator>Gao, Qing</creator><creator>Wu, Su</creator><creator>Cassady, John P</creator><general>Nature Publishing Group US</general><general>Nature Publishing Group</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>N95</scope><scope>XI7</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QO</scope><scope>7QP</scope><scope>7QR</scope><scope>7T7</scope><scope>7TK</scope><scope>7TM</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>M7S</scope><scope>MBDVC</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PTHSS</scope><scope>Q9U</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20090201</creationdate><title>Transgenic mice with defined combinations of drug-inducible reprogramming factors</title><author>Jaenisch, Rudolf ; Markoulaki, Styliani ; Hanna, Jacob ; Beard, Caroline ; Carey, Bryce W ; Cheng, Albert W ; Lengner, Christopher J ; Dausman, Jessica A ; Fu, Dongdong ; Gao, Qing ; Wu, Su ; Cassady, John P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c659t-6779c54fa382534fdf49f8ce66df1e98f10b7e70d84326efa71f3002eef3f5df3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Agriculture</topic><topic>Animals</topic><topic>Bioinformatics</topic><topic>Biological and medical sciences</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedical Engineering/Biotechnology</topic><topic>Biomedicine</topic><topic>Biotechnology</topic><topic>brief-communication</topic><topic>Cell Differentiation - drug effects</topic><topic>Cell Differentiation - genetics</topic><topic>Cells, Cultured</topic><topic>Chimera - genetics</topic><topic>Chimera - metabolism</topic><topic>DNA binding proteins</topic><topic>Doxycycline - pharmacology</topic><topic>Female</topic><topic>Fibroblasts - metabolism</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Genetic aspects</topic><topic>Genetic Techniques</topic><topic>Genetically modified mice</topic><topic>Genetics</topic><topic>Health aspects</topic><topic>Health. Pharmaceutical industry</topic><topic>Industrial applications and implications. Economical aspects</topic><topic>Kruppel-Like Transcription Factors - genetics</topic><topic>Kruppel-Like Transcription Factors - metabolism</topic><topic>Life Sciences</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Transgenic</topic><topic>Miscellaneous</topic><topic>Octamer Transcription Factor-3 - genetics</topic><topic>Octamer Transcription Factor-3 - metabolism</topic><topic>Physiological aspects</topic><topic>Pluripotent Stem Cells</topic><topic>Proto-Oncogene Proteins c-myc - genetics</topic><topic>Proto-Oncogene Proteins c-myc - metabolism</topic><topic>Proviruses - genetics</topic><topic>Proviruses - metabolism</topic><topic>Rodents</topic><topic>SOXB1 Transcription Factors - genetics</topic><topic>SOXB1 Transcription Factors - metabolism</topic><topic>Stem cells</topic><topic>Transcription Factors - drug effects</topic><topic>Transcription Factors - genetics</topic><topic>Transgenic animals</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jaenisch, Rudolf</creatorcontrib><creatorcontrib>Markoulaki, Styliani</creatorcontrib><creatorcontrib>Hanna, Jacob</creatorcontrib><creatorcontrib>Beard, Caroline</creatorcontrib><creatorcontrib>Carey, Bryce W</creatorcontrib><creatorcontrib>Cheng, Albert W</creatorcontrib><creatorcontrib>Lengner, Christopher J</creatorcontrib><creatorcontrib>Dausman, Jessica A</creatorcontrib><creatorcontrib>Fu, Dongdong</creatorcontrib><creatorcontrib>Gao, Qing</creatorcontrib><creatorcontrib>Wu, Su</creatorcontrib><creatorcontrib>Cassady, John P</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale_Business Insights: Global</collection><collection>Business Insights: Essentials</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest research library</collection><collection>Science Database</collection><collection>ProQuest Biological Science Journals</collection><collection>Engineering Database</collection><collection>Research Library (Corporate)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Engineering collection</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Nature biotechnology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jaenisch, Rudolf</au><au>Markoulaki, Styliani</au><au>Hanna, Jacob</au><au>Beard, Caroline</au><au>Carey, Bryce W</au><au>Cheng, Albert W</au><au>Lengner, Christopher J</au><au>Dausman, Jessica A</au><au>Fu, Dongdong</au><au>Gao, Qing</au><au>Wu, Su</au><au>Cassady, John P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Transgenic mice with defined combinations of drug-inducible reprogramming factors</atitle><jtitle>Nature biotechnology</jtitle><stitle>Nat Biotechnol</stitle><addtitle>Nat Biotechnol</addtitle><date>2009-02-01</date><risdate>2009</risdate><volume>27</volume><issue>2</issue><spage>169</spage><epage>171</epage><pages>169-171</pages><issn>1087-0156</issn><eissn>1546-1696</eissn><coden>NABIF9</coden><abstract>Proviruses carrying drug-inducible Oct4, Sox2, Klf4 and c-Myc used to derive 'primary' induced pluripotent stem (iPS) cells were segregated through germline transmission, generating mice and cells carrying subsets of the reprogramming factors. Drug treatment produced 'secondary' iPS cells only when the missing factor was introduced. This approach creates a defined system for studying reprogramming mechanisms and allows screening of genetically homogeneous cells for compounds that can replace any transcription factor required for iPS cell derivation.</abstract><cop>New York</cop><pub>Nature Publishing Group US</pub><pmid>19151700</pmid><doi>10.1038/nbt.1520</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1087-0156
ispartof Nature biotechnology, 2009-02, Vol.27 (2), p.169-171
issn 1087-0156
1546-1696
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2654270
source Nature
subjects Agriculture
Animals
Bioinformatics
Biological and medical sciences
Biomedical and Life Sciences
Biomedical Engineering/Biotechnology
Biomedicine
Biotechnology
brief-communication
Cell Differentiation - drug effects
Cell Differentiation - genetics
Cells, Cultured
Chimera - genetics
Chimera - metabolism
DNA binding proteins
Doxycycline - pharmacology
Female
Fibroblasts - metabolism
Fundamental and applied biological sciences. Psychology
Genetic aspects
Genetic Techniques
Genetically modified mice
Genetics
Health aspects
Health. Pharmaceutical industry
Industrial applications and implications. Economical aspects
Kruppel-Like Transcription Factors - genetics
Kruppel-Like Transcription Factors - metabolism
Life Sciences
Male
Mice
Mice, Transgenic
Miscellaneous
Octamer Transcription Factor-3 - genetics
Octamer Transcription Factor-3 - metabolism
Physiological aspects
Pluripotent Stem Cells
Proto-Oncogene Proteins c-myc - genetics
Proto-Oncogene Proteins c-myc - metabolism
Proviruses - genetics
Proviruses - metabolism
Rodents
SOXB1 Transcription Factors - genetics
SOXB1 Transcription Factors - metabolism
Stem cells
Transcription Factors - drug effects
Transcription Factors - genetics
Transgenic animals
title Transgenic mice with defined combinations of drug-inducible reprogramming factors
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T04%3A07%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Transgenic%20mice%20with%20defined%20combinations%20of%20drug-inducible%20reprogramming%20factors&rft.jtitle=Nature%20biotechnology&rft.au=Jaenisch,%20Rudolf&rft.date=2009-02-01&rft.volume=27&rft.issue=2&rft.spage=169&rft.epage=171&rft.pages=169-171&rft.issn=1087-0156&rft.eissn=1546-1696&rft.coden=NABIF9&rft_id=info:doi/10.1038/nbt.1520&rft_dat=%3Cgale_pubme%3EA199539032%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c659t-6779c54fa382534fdf49f8ce66df1e98f10b7e70d84326efa71f3002eef3f5df3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=222302306&rft_id=info:pmid/19151700&rft_galeid=A199539032&rfr_iscdi=true